Stocks and Investing Stocks and Investing
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022

Tazeen Ahmad Downgraded (BCRX) to Hold and Held Target at $14 on, Apr 11th, 2022


Published on 2024-10-27 20:23:38 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold and Held Target at $14 on, Apr 11th, 2022.

Tazeen, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30